BRL 6231

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 585421

CAS#: 30711-93-4

Description: BRL 6231 is a triazine antimalarial.

Chemical Structure

img
BRL 6231
CAS# 30711-93-4
Instruction

Theoretical Analysis

MedKoo Cat#: 585421
Name: BRL 6231
CAS#: 30711-93-4
Chemical Formula: C14H18Cl3N5O2
Exact Mass: 393.05
Molecular Weight: 394.681
Elemental Analysis: C, 42.61; H, 4.60; Cl, 26.95; N, 17.74; O, 8.11

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: BRL 6231; BRL6231; BRL-6231

IUPAC/Chemical Name: 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,3,5-triazine-2,4-diamine

InChi Key: MJZJYWCQPMNPRM-UHFFFAOYSA-N

InChi Code: InChI=1S/C14H18Cl3N5O2/c1-14(2)21-12(18)20-13(19)22(14)24-5-3-4-23-11-7-9(16)8(15)6-10(11)17/h6-7H,3-5H2,1-2H3,(H4,18,19,20,21)

SMILES Code: NC1=NC(N)=NC(C)(C)N1OCCCOC2=CC(Cl)=C(Cl)C=C2Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 394.68 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Knight DJ, Mamalis P, Peters W. The antimalarial activity of N-benzyl-oxydihydrotriazines. III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5,-trichloropropyloxy)-1,3,5-triazine hydrobromide (BRL 51084) and hydrochloride (BRL 6231). Ann Trop Med Parasitol. 1982 Feb;76(1):1-7. PubMed PMID: 7044322.

2: Nettleton MJ, Poyser RH, Shorter JH. The cardiovascular effects of two new triazine antimalarials, BRL 50216 (Clociguanil) and BRL 6231. Toxicol Appl Pharmacol. 1974 Feb;27(2):271-82. PubMed PMID: 4854671.

3: Knight DJ, Williamson P. The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei. Ann Trop Med Parasitol. 1982 Feb;76(1):9-14. PubMed PMID: 7044325.

4: Boucher MJ, Yeh E. Disruption of Apicoplast Biogenesis by Chemical Stabilization of an Imported Protein Evades the Delayed-Death Phenotype in Malaria Parasites. mSphere. 2019 Jan 23;4(1). pii: e00710-18. doi: 10.1128/mSphere.00710-18. PubMed PMID: 30674649; PubMed Central PMCID: PMC6344605.

5: Nixon MR, Saionz KW, Koo MS, Szymonifka MJ, Jung H, Roberts JP, Nandakumar M, Kumar A, Liao R, Rustad T, Sacchettini JC, Rhee KY, Freundlich JS, Sherman DR. Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosis. Chem Biol. 2014 Jul 17;21(7):819-30. doi: 10.1016/j.chembiol.2014.04.009. Epub 2014 Jun 19. PubMed PMID: 24954008.

6: Asada M, Yahata K, Hakimi H, Yokoyama N, Igarashi I, Kaneko O, Suarez CE, Kawazu S. Transfection of Babesia bovis by Double Selection with WR99210 and Blasticidin-S and Its Application for Functional Analysis of Thioredoxin Peroxidase-1. PLoS One. 2015 May 11;10(5):e0125993. doi: 10.1371/journal.pone.0125993. eCollection 2015. PubMed PMID: 25962142; PubMed Central PMCID: PMC4427477.

7: Cho S, Yang S, Rhie H. The gene encoding the alternative thymidylate synthase ThyX is regulated by sigma factor SigB in Corynebacterium glutamicum ATCC 13032. FEMS Microbiol Lett. 2012 Mar;328(2):157-65. doi: 10.1111/j.1574-6968.2011.02494.x. Epub 2012 Jan 16. PubMed PMID: 22224900.

8: Kamchonwongpaisan S, Vanichtanankul J, Taweechai S, Chitnumsub P, Yuthavong Y. The role of tryptophan-48 in catalysis and binding of inhibitors of Plasmodium falciparum dihydrofolate reductase. Int J Parasitol. 2007 Jun;37(7):787-93. Epub 2007 Jan 14. PubMed PMID: 17320089.

9: Nirmalan N, Sims PF, Hyde JE. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors. Mol Biochem Parasitol. 2004 Jul;136(1):63-70. PubMed PMID: 15138068.

10: Canfield CJ, Milhous WK, Ager AL, Rossan RN, Sweeney TR, Lewis NJ, Jacobus DP. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists. Am J Trop Med Hyg. 1993 Jul;49(1):121-6. PubMed PMID: 8352384.

11: Auliff AM, Balu B, Chen N, O'Neil MT, Cheng Q, Adams JH. Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum. PLoS One. 2012;7(7):e40416. doi: 10.1371/journal.pone.0040416. Epub 2012 Jul 9. PubMed PMID: 22792308; PubMed Central PMCID: PMC3392216.

12: Fidock DA, Nomura T, Wellems TE. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol Pharmacol. 1998 Dec;54(6):1140-7. PubMed PMID: 9855645.

13: Fidock DA, Wellems TE. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10931-6. PubMed PMID: 9380737; PubMed Central PMCID: PMC23535.

14: Maier AG, Braks JA, Waters AP, Cowman AF. Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. Mol Biochem Parasitol. 2006 Nov;150(1):118-21. Epub 2006 Jul 25. PubMed PMID: 16901558.

15: Meyer SC, Majumder SK, Cynamon MH. In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex. Antimicrob Agents Chemother. 1995 Aug;39(8):1862-3. PubMed PMID: 7486934; PubMed Central PMCID: PMC162841.

16: Wooden JM, Hartwell LH, Vasquez B, Sibley CH. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. Mol Biochem Parasitol. 1997 Mar;85(1):25-40. PubMed PMID: 9108546.

17: Hunt SY, Rezvani BB, Sibley CH. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil. Mol Biochem Parasitol. 2005 Jan;139(1):25-32. PubMed PMID: 15610816.

18: Janse CJ, Ramesar J, Waters AP. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc. 2006;1(1):346-56. PubMed PMID: 17406255.

19: Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg. 2006 Oct;75(4):617-21. PubMed PMID: 17038682.

20: Hekmat-Nejad M, Rathod PK. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase. Exp Parasitol. 1997 Nov;87(3):222-8. PubMed PMID: 9371087.